212 related articles for article (PubMed ID: 2258906)
1. Structure-activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyrans.
Saeed A; Sharma AP; Durani N; Jain R; Durani S; Kapil RS
J Med Chem; 1990 Dec; 33(12):3210-6. PubMed ID: 2258906
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans.
Sharma AP; Saeed A; Durani S; Kapil RS
J Med Chem; 1990 Dec; 33(12):3216-22. PubMed ID: 2258907
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of antiestrogens. Phenolic analogues of 2,3-diaryl-2H-1-benzopyrans.
Sharma AP; Saeed A; Durani S; Kapil RS
J Med Chem; 1990 Dec; 33(12):3222-9. PubMed ID: 2258908
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of antiestrogens: a study using triarylbutenone, benzofuran, and triarylfuran analogues as models for triarylethylenes and triarylpropenones.
Durani N; Jain R; Saeed A; Dikshit DK; Durani S; Kapil RS
J Med Chem; 1989 Aug; 32(8):1700-7. PubMed ID: 2754694
[TBL] [Abstract][Full Text] [Related]
5. (S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen.
Gauthier S; Caron B; Cloutier J; Dory YL; Favre A; Larouche D; Mailhot J; Ouellet C; Schwerdtfeger A; Leblanc G; Martel C; Simard J; Mérand Y; Bélanger A; Labrie C; Labrie F
J Med Chem; 1997 Jul; 40(14):2117-22. PubMed ID: 9216828
[No Abstract] [Full Text] [Related]
6. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
Jordan VC; Gosden B
Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
[TBL] [Abstract][Full Text] [Related]
7. Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.
Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
J Pharmacol Exp Ther; 2002 Mar; 300(3):802-9. PubMed ID: 11861784
[TBL] [Abstract][Full Text] [Related]
8. Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptor.
Jordan VC; Gosden B
J Steroid Biochem; 1983 Sep; 19(3):1249-58. PubMed ID: 6684713
[TBL] [Abstract][Full Text] [Related]
9. Resolution, molecular structure and biological activities of the D- and L-enantiomers of potent anti-implantation agent, DL-2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-2H-1-benzopyran.
Hajela K; Pandey J; Dwivedy A; Dhar JD; Sarkhel S; Maulik PR; Velumurugan D
Bioorg Med Chem; 1999 Sep; 7(9):2083-90. PubMed ID: 10530958
[TBL] [Abstract][Full Text] [Related]
10. Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length.
Hardcastle IR; Rowlands MG; Grimshaw RM; Houghton J; Jarman M
J Med Chem; 1996 Feb; 39(4):999-1004. PubMed ID: 8632423
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of 4-methylestradiol.
Qian XD; Abul-Hajj YJ
J Steroid Biochem; 1990 May; 35(6):745-7. PubMed ID: 2362436
[TBL] [Abstract][Full Text] [Related]
12. 1-(aminoalkyl)-2-phenylindoles as novel pure estrogen antagonists.
von Angerer E; Knebel N; Kager M; Ganss B
J Med Chem; 1990 Sep; 33(9):2635-40. PubMed ID: 2391702
[TBL] [Abstract][Full Text] [Related]
13. Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterus.
Jordan VC; Gosden B
Mol Cell Endocrinol; 1982 Aug; 27(3):291-306. PubMed ID: 7128917
[No Abstract] [Full Text] [Related]
14. Antiestrogen basicity--activity relationships: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (tamoxifen, Nolvadex) having altered basicity.
Robertson DW; Katzenellenbogen JA; Hayes JR; Katzenellenbogen BS
J Med Chem; 1982 Feb; 25(2):167-71. PubMed ID: 7057423
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and estrogen receptor binding affinities of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-ones containing a basic side chain.
Kim YW; Mobley JA; Brueggemeier RW
Bioorg Med Chem Lett; 2003 Apr; 13(8):1475-8. PubMed ID: 12668015
[TBL] [Abstract][Full Text] [Related]
16. Structure activity relationship of some 2,3-diaryl-2H-1-benzopyrans to their anti-implantation, estrogenic and antiestrogenic activities in rat.
Dhar JD; Dwivedi A; Srivastava A; Setty BS
Contraception; 1994 Jun; 49(6):609-16. PubMed ID: 8070266
[TBL] [Abstract][Full Text] [Related]
17. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the biological effects of tamoxifen and a new antioestrogen (LY 117018) on the immature rat uterus.
Wakeling AE; O'Connor KM; Newboult E
J Endocrinol; 1983 Dec; 99(3):447-53. PubMed ID: 6644235
[TBL] [Abstract][Full Text] [Related]
19. Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms.
Black LJ; Goode RL
Endocrinology; 1981 Sep; 109(3):987-9. PubMed ID: 7262030
[TBL] [Abstract][Full Text] [Related]
20. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
Borgna JL; Scali J
Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
